- Home
- IMCC vs TTNP Comparison
IMCC vs TTNP Comparison
Compare IMCC & TTNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMCC
- TTNP
- Stock Information
- Founded
- IMCC 1980
- TTNP 1991
- Country
- IMCC Israel
- TTNP United States
- Employees
- IMCC N/A
- TTNP N/A
- Industry
- IMCC Medicinal Chemicals and Botanical Products
- TTNP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- IMCC Health Care
- TTNP Health Care
- Exchange
- IMCC Nasdaq
- TTNP Nasdaq
- Market Cap
- IMCC 5.3M
- TTNP 5.9M
- IPO Year
- IMCC N/A
- TTNP 1996
- Fundamental
- Price
- IMCC $2.52
- TTNP $4.26
- Analyst Decision
- IMCC
- TTNP
- Analyst Count
- IMCC 0
- TTNP 0
- Target Price
- IMCC N/A
- TTNP N/A
- AVG Volume (30 Days)
- IMCC 406.8K
- TTNP 44.1K
- Earning Date
- IMCC 08-13-2025
- TTNP 08-14-2025
- Dividend Yield
- IMCC N/A
- TTNP N/A
- EPS Growth
- IMCC N/A
- TTNP N/A
- EPS
- IMCC N/A
- TTNP N/A
- Revenue
- IMCC $37,894,737.00
- TTNP N/A
- Revenue This Year
- IMCC $47.12
- TTNP N/A
- Revenue Next Year
- IMCC $12.83
- TTNP N/A
- P/E Ratio
- IMCC N/A
- TTNP N/A
- Revenue Growth
- IMCC 12.68
- TTNP N/A
- 52 Week Low
- IMCC $1.29
- TTNP $3.03
- 52 Week High
- IMCC $7.12
- TTNP $14.80
- Technical
- Relative Strength Index (RSI)
- IMCC 47.04
- TTNP 46.55
- Support Level
- IMCC $2.67
- TTNP $4.17
- Resistance Level
- IMCC $2.95
- TTNP $4.65
- Average True Range (ATR)
- IMCC 0.37
- TTNP 0.20
- MACD
- IMCC -0.07
- TTNP -0.03
- Stochastic Oscillator
- IMCC 18.98
- TTNP 26.98
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.
About TTNP Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.